SGLT2 Inhibition and Heart Failure: Translating the Evidence to Clinical Practice

Educational Activity



Javed Butler, MD, MPH, MBA

Professor and Chair

Department of Medicine

University of Mississippi

Jackson, Mississippi


Faculty Listing


Mikhail Kosiborod, MD

Vice President, Research

Saint Luke’s Health System

Professor of Medicine

University of Missouri—Kansas City

Kansas City, Missouri


Alanna Morris, MD, MSc

Director of Heart Failure Research

Associate Professor of Medicine

Emory University Clinical Cardiovascular Research Institute

Atlanta, Georgia


Muthiah Vaduganathan, MD, MPH

Brigham and Women’s Hospital

Instructor of Medicine

Harvard Medical School

Boston, Massachusetts


Faculty Disclosures


In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.


Any person who may contribute to the content of this continuing educa­tion activity must disclose relevant relationships (and any known relation­ships of their spouse/partner) with commercial interests whose products or services are discussed in educational presentations. A commercial inter­est is defined as any entity producing, marketing, re-selling, or distribut­ing health care goods or services consumed by, or used on, patients. Relevant relationships include receiving from a commercial interest research grant, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.


Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with infor­mation that might be of potential importance to their evaluation of a presentation.


Javed Butler, MD, MPH, MBA


Therapeutics; AstraZeneca; Bayer; Boehringer Ingelheim;

BMS; CVRx; G3 Pharma; Impulse Dynamics; Janssen;

LivaNova; Luitpold; Medtronic; Merck; Novartis; Novo

Nordisk; Occlutech; Pfizer; Roche; Sequana Medical; Vifor

SPEAKER-HONORARIA: AstraZeneca; Boehringer Ingelheim;

Janssen; Merck; Novartis


Mikhail Kosiborod, MD

RESEARCH GRANT: AstraZeneca; Boehringer Ingelheim

SPEAKER-HONORARIA: Amgen; Applied Therapeutics;

AstraZeneca; Bayer; Boehringer Ingelheim; Eli Lilly; Janssen;

Merck (Diabetes); Novo Nordisk; Sanofi; Vifor Pharma


Alanna Morris, MD, MSc

Dr. Morris has indicated she has nothing to disclose.


Muthiah Vaduganathan, MD, MPH

RESEARCH GRANT: Amgen; AstraZeneca; Boehringer

Ingelheim; Galmed; Novartis

SPEAKER-HONORARIA: Novartis; Roche Diagnostics


AstraZeneca; Bayer AG; Baxter Healthcare; Boehringer

Ingelheim; Cytokinetics; Lexicon Pharmaceuticals; Relypsa;

Roche Diagnostics


NOTE: The following planner has indicated that he has

nothing to disclose:

John Kocsis, PhD – President


Powered by Oasis.